Medipharm Labs Corp T.LABS

Alternate Symbol(s): MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.

TSX:LABS - Post by User

Medipharm Labs Corp > LABS sells Australian subsidiary

<< Previous

Bullboard Posts

Next >>

Comment by subaru1on Jul 12, 2022 1:04pm

242 Views

Post# 34818433

RE:LABS sells Australian subsidiary

In other news, the company recently completed a review of its international manufacturing platform, identifying considerable potential savings by shifting all manufacturing to its Canadian facility. More concrete details about these discussions aren’t available at this time.

Some other things are boiling it sound interesting, at least the last Ceo seems to be in action, let see what comes out of this review.

Now we nee a good I.R. to keep us well informed of what is going on.

<< Previous

Bullboard Posts

Next >>

Quantum eMotion leaps by 20 per cent after Becton Dickinson deal